Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotechs In Motion As New Drug Pipeline Brims
investors.com
Sunday, July 29, 2012 - 1:00pm
tags:
Amgen, Celgene, Biogen Idec, Gilead Sciences, Regeneron, Vertex Pharmaceuticals, Alexion, Arena Pharmaceuticals, ONYX Pharmaceuticals, United Therapeutics
Mylan Launches Generic Version of Sporanox® Capsules By Mylan Inc.
Sacramento Bee, CA
Sunday, July 29, 2012 - 12:58pm
tags:
Mylan, Sporanox, generics, Janssen, blatsomycosis, histoplasmosis, aspergillosis
Dendreon Earnings Approach
Wall Street Cheat Street
Sunday, July 29, 2012 - 12:27pm
tags:
Dendreon, earnings
Hyperion Therapeutics Goes Public
Seeking Alpha
Sunday, July 29, 2012 - 12:22pm
tags:
Hyperion Therapeutics
Buy, Sell, or Hold: Amarin
Motley Fool
Sunday, July 29, 2012 - 12:14pm
tags:
Amarin
A Closer Look At Repros Therapeutics
Seeking Alpha
Sunday, July 29, 2012 - 12:14pm
tags:
Repros Therapeutics
What is Holding Back JNJ from Pulling Up?
Motley Fool
Sunday, July 29, 2012 - 12:13pm
tags:
JNJ
Is This the End of MannKind?
Motley Fool
Sunday, July 29, 2012 - 12:12pm
tags:
MannKind
IBM's Reinvention Should Inspire Flat Pharma Businesses
Forbes
Sunday, July 29, 2012 - 12:11pm
tags:
Bio Buyouts
Motley Fool
Sunday, July 29, 2012 - 12:10pm
tags:
Seattle Genetics, Alexion, Regeneron, Biomarin, Vertex Pharmaceuticals, Idenix, Obagi Medical Products
Why the Shorts Are Attacking VIVUS
Motley Fool
Saturday, July 28, 2012 - 11:46am
tags:
Vivus, Qsymia
Small-Cap Adjuvants For Cancer Treatment
Seeking Alpha
Saturday, July 28, 2012 - 11:32am
tags:
Agenus, QS-21, OncoSec Medical, OMS ElectroImmunotherapy, Oncothyreon, ONO-4641, Stimuvax
Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Yahoo/BusinessWire
Saturday, July 28, 2012 - 11:28am
tags:
Progenics Pharmaceuticals, Salix, Relistor, opiod-induced constipation, constipation
No Huddle Offense: Biotech Plays (video)
Yahoo/CNBC
Saturday, July 28, 2012 - 11:24am
tags:
Forget the Numbers, This Pipeline Is King
Motley Fool
Saturday, July 28, 2012 - 11:15am
tags:
Gilead Sciences, Quad, HIV, GS-7977, hepatitis C
FDA lifts import alert from Dr. Reddy's Labs Mexico facility
Yahoo/Fly on the Wall
Friday, July 27, 2012 - 1:03pm
tags:
FDA, Dr Reddy's, Mexico
Allergan Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, July 27, 2012 - 12:58pm
tags:
earnings, Allergan
With FDA panel nod, ThromboGenics closer to first potential drug
Fierce Biotech
Friday, July 27, 2012 - 12:52pm
tags:
FDA, ThromboGenics, ocriplasmin, vitreomacular adhesion
Pay Attention to These Biotechs
Yahoo/TheStreet.com
Friday, July 27, 2012 - 12:50pm
tags:
Gilead, Amgen, Celgene
Amarin Falls After U.S. Approval Limits Debut Drug’s Use
Bloomberg
Friday, July 27, 2012 - 12:17pm
tags:
Amarin, FDA, Vascepa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.